CXO

4.17%

11.5¢ core lithium ltd

80c geese that's 15-16 times my initial I'll take that

First 13903 Last

Share
Profile

Follow
BattleOfHastings

825 Posts.

171

31/08/22

20:19

Post #: 63445192
Share

Originally posted by PM4: ↑

For those interested, research form a couple of brokers. On another service they put out forecasts to FY24 and put CXO on a PE 6.5 and a Div of 6.5 or 4.6%

COMMENTARY
Macquarie initiates coverage on Core Lithium, noting development of the company's Finniss spodumene project is well underway and remains on track to deliver first spodumene production in the first half of 2023.
The company has secured offtake agreements with Genfeng and Ya Hua for around 80% of anticipated production for the first five years, and remains in talks over a third offtake agreement with Tesla.
The broker expects timing of the development will see Core Lithium benefit from buoyant pricing. The broker initiates with an Outperform rating and target price of $1.80.
FORECAST
Macquarie forecasts a full yearFY22dividend of0.00cents and EPS ofminus -0.60cents.
Macquarie forecasts a full yearFY23dividend of0.80cents and EPS of2.20cents

Canaccord Genuity rates ((CXO)) as Downgrade to Hold from Speculative Buy (3) –
While analysts at Canaccord Genuity lower 2022-24 electric vehicle forecasts, any lithium demand impacts are offset by increased average battery sizes.
Demand growth is expected to outpace supply until 2030 and higher pricing will be needed to incentivise new supply.
The broker raises its forecasts for 2022-25 average Li2CO3/LiOH prices, and generally prefers producers over developers in the near term on relative valuations and pricing leverage. Average target prices across the lithium coverage are raised by 15%.
Canaccord downgrades its rating for Core Lithium to Hold from Speculative Buy on valuation and raises its target to $1.50 from $1.00.
This report was published on August 22, 2022.
Target price is$1.50Current Price is$1.40Difference:$0.1
IfCXOmeets the Canaccord Genuity target it will return approximately7%(excluding dividends, fees and charges).
The company's fiscal year ends in June.

Expand

80c geese that's 15-16 times my initial I'll take that

CXO Price at posting: $1.40 Sentiment: Buy Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

BUX

Buxton projects new graphite province discovery at WA Narryer play

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

There are more pages in this discussion • 25,405 more messages in this thread...

First 13903 Last

Add CXO (ASX) to my watchlist

(20min delay)
Last 11.5¢		Change -0.005(4.17%)		Mkt cap ! $246.4M

Open	High	Low	Value	Volume
11.5¢	12.0¢	11.3¢	$1.220M	10.57M

Buyers (Bids)

No.	Vol.	Price($)
110	6252092	11.0¢

Sellers (Offers)

Price($)	Vol.	No.
11.5¢	695532	1

View Market Depth

No.	Vol.	Price($)
108	6148461	0.110
63	5154165	0.105
124	9216878	0.100
12	535155	0.099
16	761902	0.098

Price($)	Vol.	No.
0.115	695532	1
0.120	1962872	25
0.125	2224659	24
0.130	3549128	51
0.135	2008820	34

Last trade - 16.10pm 04/10/2024 (20 minute delay)

CXO (ASX) Chart

80c geese that's 15-16 times my initial I'll take that

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Buxton projects new graphite province discovery at WA Narryer play

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

BCI reaches close of funding facility for salt-first part of Mardie project

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

80c geese that's 15-16 times my initial I'll take that

Top Stories

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Buxton projects new graphite province discovery at WA Narryer play

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

BCI reaches close of funding facility for salt-first part of Mardie project

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News